Financing channel feed – Endpoints News

Financing channel feed

Biotech boards burdened: Bridging the success gap

6 years ago

BenevolentAI draws $90M from Temasek amid reports of halved valuation

6 years ago

Preclinical cancer biotech IGM Biosciences sets stage for upsized $175M IPO

6 years ago

Merck helps bankroll new partner Themis' game plan to finish the chikungunya race and begin oncolytic virus quest

6 years ago

Swiss biotech raises $16M to test 'undelivery mechanism' for rare liver disease

6 years ago

BenevolentAI's latest financing could halve its $2B valuation — and that has Woodford watchers worried

6 years ago

Chalk up a big win for Bain as SpringWorks IPO tops out at $162M

6 years ago

Roche vet Jean-Jacques Garaud woos international believers in his French startup's take on septic shock

6 years ago

How about a $477M biotech IPO amid Hong Kong protests? Henlius will find out

6 years ago

Hong Kong strife holds up almost $100M of BioNTech's Series B haul

6 years ago

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

6 years ago

Alex Zhavoronkov follows landmark AI paper with $37M round for Insilico featuring top-notch China VCs

6 years ago

Fresh off the heels of mega financing round, Germany's BioNTech makes $100M US IPO play

6 years ago

Three biotechs hunt $336M-plus in a new round of IPOs — while Dermavant pulls back

6 years ago

London's 4BIO Capital unveils first close of $150M fund dedicated to advanced therapies

6 years ago

Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B

6 years ago

Versant-backed precision oncology startup Repare Therapeutics scores $82M+ in latest round

6 years ago

Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty

6 years ago

Nkarta maps out clinical, manufacturing plans for CAR-NK following $114M round led by Samsara

6 years ago

George Scangos heads back to Wall Street. And he’s bringing along some of the best connections in biotech

6 years ago

Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug

6 years ago

Syncona dives deep into dry AMD R&D, upping Gyroscope bet to $100M

6 years ago

RA Capital-backed cell therapy player in the neoantigen game grabs a $121M megaround to fund first human studies

6 years ago

On track for first autoimmune drug approval, Bing Yao steers AstraZeneca spinoff to $150M IPO

6 years ago

First page Previous page 108 109 110111112 113 114 Next page Last page